RCM
SPPI

Rotella Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Rotella Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,700
Closed -$77K – 262
2015
Q4 		$77K Sell
12,700
-20,900
-62% -$120K 0.07% 344
2015
Q3 		$201K Buy
+33,600
New +$233K 0.06% 327

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Rotella Capital Management's SPPI Position: Q1 2016 in Review

Rotella Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2016, closing a stake of 12,700 shares — an estimated $77K sold.

Rotella Capital Management first reported a position in SPPI in Q3 2015 and held it in 2 quarters. The position peaked at $201K in Q3 2015. 131 funds tracked by Wall St. Rank hold SPPI as of Q1 2016.

  • Rotella Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 12,700 Spectrum Pharmaceuticals Inc shares in Q1 2016, an estimated $77K.
  • Rotella Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2015 and held it in 2 quarters.
  • Rotella Capital Management's Spectrum Pharmaceuticals Inc position peaked at $201K in Q3 2015.
  • 131 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.